Where is the live CopyMark page for USPTO serial 87416893?

The live record is at https://getcopymark.com/trademark/87416893. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns BEAUTIFUL MEDICINE?

According to the public USPTO record for serial number 87416893, the listed owner(s) include: BREAST ENHANCEMENT CENTERS OF AMERICA - CORPORATE LLC, NU INSTITUTE FOR AGE MANAGEMENT AND INTERVENTION, LLC ..

What is USPTO serial number 87416893?

Serial number 87416893 is the USPTO application identifier for the mark BEAUTIFUL MEDICINE. It is used to track examination, publication, and registration of this trademark.

What is the current status of BEAUTIFUL MEDICINE?

BEAUTIFUL MEDICINE (87416893) currently shows USPTO status code 603 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover BEAUTIFUL MEDICINE?

The public record lists International Classes: 044. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: BEAUTIFUL MEDICINE Serial# 87416893 | status 603; last event MAB3 | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BEAUTIFUL MEDICINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Augusto Perera, Esq.

AUGUSTO PERERA ESQ AUGUSTO PERERA PA2525 PONCE DE LEON BLVDSUITE 300CORAL GABLES, FL 33134

Goods and services

Class	Description	Status	First use
044	plastic surgery of the face, breast and body	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jun 20, 2019	MAB3	ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL	—
Jun 13, 2019	ABN3	ABANDONMENT - AFTER EX PARTE APPEAL	—
Jun 13, 2019	EXPT	EXPARTE APPEAL TERMINATED	—
Mar 29, 2019	EXPA	EX PARTE APPEAL-REFUSAL AFFIRMED	—
Dec 15, 2018	RBFT	REPLY BRIEF FILED - CHECK TTAB FILES	—
Nov 28, 2018	GNSN	NOTIFICATION OF EXAMINERS STATEMENT E-MAILED	—
Nov 28, 2018	GNES	EXAMINERS STATEMENT E-MAILED	—
Nov 28, 2018	CNES	EXAMINERS STATEMENT - COMPLETED	—
Oct 19, 2018	ARAA	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 19, 2018	REAP	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	—
Oct 2, 2018	JURT	JURISDICTION RESTORED TO EXAMINING ATTORNEY	—
Aug 9, 2018	EXPI	EX PARTE APPEAL-INSTITUTED	—
Aug 9, 2018	EXAF	EXPARTE APPEAL RECEIVED AT TTAB	—
Aug 8, 2018	RDX3	NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED	—
Aug 8, 2018	RDX1	ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED	—
Aug 8, 2018	RRDX	ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED	—
Jul 17, 2018	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Jul 17, 2018	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jul 17, 2018	ERFR	TEAS REQUEST FOR RECONSIDERATION RECEIVED	—
Mar 28, 2018	ASGN	AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	—
Feb 12, 2018	GNFN	NOTIFICATION OF FINAL REFUSAL EMAILED	—
Feb 12, 2018	GNFR	FINAL REFUSAL E-MAILED	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 12, 2018	CNFR	FINAL REFUSAL WRITTEN	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 20, 2018	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Jan 20, 2018	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jan 20, 2018	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 23, 2017	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 23, 2017	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 23, 2017	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 14, 2017	DOCK	ASSIGNED TO EXAMINER	—
Apr 25, 2017	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Apr 22, 2017	NWAP	NEW APPLICATION ENTERED	—

BEAUTIFUL MEDICINE